| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/15/2009 | US20090017015 Dpp-iv inhibitors for treating neurodegeneration and cognitive disorders |
| 01/15/2009 | US20090017013 cyclosporine; autoimmunity to type V collagen ; for Idiopathic Pulmonary Fibrosis, Adult Respiratory Distress Syndrome, Acute Respiratory Distress Syndrome, secondary collagen vascular disease, any form of fibrotic lung disease |
| 01/15/2009 | US20090017011 Modulation of vegf-c/vegfr-3 interactions in the treatment of rheumatoid arthritis |
| 01/15/2009 | US20090017009 Method for the diagnosis and prognosis of malignant diseases |
| 01/15/2009 | US20090017008 Compositions and methods for altering bone density and bone patterning |
| 01/15/2009 | US20090017006 Use of a compound for enhancing the expression of membrane proteins on the cell surface |
| 01/15/2009 | US20090017003 Thiosulfonate anti-inflammatory agents |
| 01/15/2009 | US20090017002 Prevention and treatment of oxidative stress disorders by glutathione and phase ii detoxification enzymes |
| 01/15/2009 | US20090016991 Rxr Antagonist Treatment Against Multiple Sclerosis |
| 01/15/2009 | US20090016988 Modified Pore-Forming Protein Toxins and Use Thereof |
| 01/15/2009 | US20090016986 Cosmetic Composition, a Pharmaceutical Composition and a Process for Preparing Said Compositions |
| 01/15/2009 | US20090016984 lanthanum polystyrene sulfonate; gastrointestinal administration |
| 01/15/2009 | US20090016970 Continuous spray scalp therapy and dispensing systems for same |
| 01/15/2009 | US20090016968 Composition and method for prevention and treatment of type i diabetes |
| 01/15/2009 | US20090016967 Compositions and methods for the treatment of respiratory disorders |
| 01/15/2009 | US20090016963 Genes involved in neurodegenerative conditions |
| 01/15/2009 | US20090013998 Inhalable tiotropium and container therefor |
| 01/15/2009 | US20090013652 Method and Apparatus for Loading a Container with a Product |
| 01/15/2009 | DE102007043187A1 Inhibierung des Hepatitis B-Virus durch Cyclohexenonverbindungen aus Antrodia camphorata Inhibition of hepatitis B virus by cyclohexenone from Antrodia camphorata |
| 01/15/2009 | DE102007032800A1 Nichtsteroidale Progesteronrezeptor-Modulatoren Non-steroidal progesterone receptor modulators |
| 01/15/2009 | DE102007032739A1 Chinazolinamidderivate Chinazolinamidderivate |
| 01/15/2009 | DE102007032664A1 Cosmetic or dermatological preparations for skin care, protection and cleaning, containing apiogalacturonan compounds or extracts thereof from seaweed, together with molecular oxygen |
| 01/15/2009 | DE102007032663A1 Cosmetic or dermatological preparations for skin care, protection and cleaning, containing apiogalacturonan compounds or extracts thereof from seaweed, together with UV light absorbers |
| 01/15/2009 | DE102007032661A1 Cosmetic or dermatological preparations for skin care and cleaning, containing apiogalacturonan compounds or extracts thereof from seaweed, together with emulsifiers |
| 01/15/2009 | DE102007032660A1 Formulation for use as cosmetic for care and protection of skin from intrinsic or extrinsic aged factor, comprises one or multiple apio galacturonans or one or multiple apio galacturonans having extract of Zostera marina |
| 01/15/2009 | DE102007032349A1 Imidazo-, Pyrazolopyrazine und Imidazotriazine und ihre Verwendung Imidazo, Pyrazolopyrazine and imidazotriazines and their use |
| 01/15/2009 | DE102007032347A1 Aminoacyl-Prodrugs Aminoacyl prodrugs |
| 01/15/2009 | DE102007032345A1 Aminoacyl-Prodrugs Aminoacyl prodrugs |
| 01/15/2009 | DE102007032344A1 Prodrug-Derivate von Prodrug derivatives of 1-(4-Methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridin-3-carboxamid |
| 01/15/2009 | DE102007030495A1 Use of creatine containing preparation e.g. for improving memory, retentivity, long-term memory and for preventing mental fatigue condition, comprising e.g. Ginkgo biloba, ginseng and niacin |
| 01/15/2009 | DE102007028095A1 Zubereitung zur Behandlung von Hufrehe bei Equiden Preparation for the treatment of laminitis in horses |
| 01/15/2009 | CA2730221A1 Oil in water emulsion comprising nsaids and quaternary ammonium halides |
| 01/15/2009 | CA2728568A1 Composition and packaging method for animal dental care |
| 01/15/2009 | CA2717788A1 Substituted nucleoside derivatives with antiviral and antimicrobial properties |
| 01/15/2009 | CA2707344A1 Stable salts of s-adenosylmethionine and process for the preparation thereof |
| 01/15/2009 | CA2702317A1 Novel pyrimidinecarboxamide derivatives |
| 01/15/2009 | CA2695330A1 Inhibitors of akt/pkb with anti-tumor activity |
| 01/15/2009 | CA2695126A1 Novel crystals and process of making 5-({[2-amino-3-(4-carbamoyl-2,6-dimethyl-phenyl)-propionyl]-[1-(4-phenyl-1h-imidazol-2-yl)-ethyl]-amino}-methyl)-2-methoxy- benzoic acid |
| 01/15/2009 | CA2695040A1 Stable pharmaceutical composition of a water-soluble vinorelbine salt |
| 01/15/2009 | CA2695039A1 Stable pharmaceutical composition comprising a hydrosoluble vinflunine salt |
| 01/15/2009 | CA2694277A1 Stable formulations of thiadiazole derivatiive |
| 01/15/2009 | CA2693697A1 Treatment of progressive neurodegenerative disease with ibudilast |
| 01/15/2009 | CA2693695A1 Biofilm treatment |
| 01/15/2009 | CA2693670A1 Synergistic combinations for treating hypertension |
| 01/15/2009 | CA2693644A1 Chitosan carboxyalkylamide hydrogel, preparation thereof and cosmetic and dermatological use thereof |
| 01/15/2009 | CA2693628A1 New combination for use in the treatment of imflammatory disorders |
| 01/15/2009 | CA2693609A1 Oral pharmaceutical solutions containing telbivudine |
| 01/15/2009 | CA2693603A1 Aminoacyl prodrugs |
| 01/15/2009 | CA2693507A1 Aminoacyl prodrugs as an active pharmaceutical ingredient for thromboembolic disorders |
| 01/15/2009 | CA2693416A1 Methods for reducing allergies caused by environmental allergens |
| 01/15/2009 | CA2693396A1 Malonamide derivatives with antithrombotic activity |
| 01/15/2009 | CA2693044A1 Crystalline form of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2 pyrimidinyl]amino]benzonitrile |
| 01/15/2009 | CA2692977A1 Methods and compositions for the treatment of cancer, tumors, and tumor-related disorders |
| 01/15/2009 | CA2692973A1 Patient selection and therapeutic methods using markers of prostaglandin metabolism |
| 01/15/2009 | CA2692945A1 Compounds - 945 |
| 01/15/2009 | CA2692805A1 Use of nitric oxide releasing compounds in the treatment of chronic pain |
| 01/15/2009 | CA2692801A1 Methods of inhibiting the formation of amyloid-.beta. diffusable ligands using acylhydrazide compounds |
| 01/15/2009 | CA2692783A1 Quinazolinone t-type calcium channel antagonists |
| 01/15/2009 | CA2692775A1 Methods of enhancing cognitive function using non-peptidic compounds |
| 01/15/2009 | CA2692773A1 Methods of modifying amyloid .beta. oligomers using non-peptidic compounds |
| 01/15/2009 | CA2692761A1 Fused heteroaryl pyridyl and phenyl benzenesulfonamides as ccr2 modulators for the treament of inflammation |
| 01/15/2009 | CA2692740A1 Immunostimulating polyphosphazene compounds for intradermal immunization |
| 01/15/2009 | CA2692738A1 O-desmethylvenlafaxine |
| 01/15/2009 | CA2692727A1 8-beta-substituted estratrienes as selectively active estrogens |
| 01/15/2009 | CA2692725A1 Compound - 946 |
| 01/15/2009 | CA2692720A1 Morpholino pyrimidine derivatives used in diseases linked to mtor kinase and/or pi3k |
| 01/15/2009 | CA2692653A1 Pyrazolo[1,5-.alpha.]pyridines and their use in cancer therapy |
| 01/15/2009 | CA2692611A1 Di(arylamino)aryl compounds |
| 01/15/2009 | CA2692610A1 Pharmaceutical preparations containing highly volatile silicones |
| 01/15/2009 | CA2692608A1 Amino acid derivatives |
| 01/15/2009 | CA2692606A1 Inhalable solid amorphous particles comprising tiotropiium bromide and a co-solid |
| 01/15/2009 | CA2692598A1 Derivatives of urea and related diamines, methods for their manufacture, and uses therefor |
| 01/15/2009 | CA2692549A1 Optically active n-(alpha-mercaptopropionyl)glycine |
| 01/15/2009 | CA2692539A1 New pharmaceutical formulation comprising cannabidiol and tetrahydrocannabidivarin |
| 01/15/2009 | CA2692515A1 Crosslinked polyallylamine or acid addition salt thereof, and use thereof for medical purposes |
| 01/15/2009 | CA2692485A1 Compounds and methods for modulating rho gtpases |
| 01/15/2009 | CA2692482A1 Pharmaceutical composition for topical application of poorly soluble compounds |
| 01/15/2009 | CA2692394A1 Fatty acid compositions and methods of use |
| 01/15/2009 | CA2692331A1 Modulators of pharmacokinetic properties of therapeutics |
| 01/15/2009 | CA2692234A1 Treatment of melanoma |
| 01/15/2009 | CA2691917A1 Crystalline pyridazine compound |
| 01/15/2009 | CA2691842A1 Thermostabilization of proteins |
| 01/15/2009 | CA2691632A1 Carbostyril derivatives including cilostazol for treating fatty liver |
| 01/15/2009 | CA2691542A1 Tetrahydropyranochromene gamma secretase inhibitors |
| 01/15/2009 | CA2691398A1 Dermatological composition containing calcitriol lipidic vesicles, method for preparing same and use thereof |
| 01/15/2009 | CA2690756A1 Novel compounds as cannabinoid receptor ligands |
| 01/15/2009 | CA2690719A1 Treatment of neuropathic pain |
| 01/15/2009 | CA2690349A1 Derivatives of 7-alkynyl-1,8-naphthyridones, preparation method thereof and use of same in therapeutics |
| 01/15/2009 | CA2690337A1 Derivatives of 7-alkynyl-1,8-naphthyridones, preparation method thereof and use of same in therapeutics |
| 01/15/2009 | CA2687750A1 Substituted amino-quinazolinones, medicaments comprising said compound, their use and their method of manufacture |
| 01/15/2009 | CA2683712A1 Pharmaceutical compositions |
| 01/15/2009 | CA2681624A1 P1-nonepimerizable ketoamide inhibitors of hcv ns3 protease |
| 01/14/2009 | EP2015070A1 Novel marker for sensitivity against sulfonamide compound |
| 01/14/2009 | EP2014776A2 Diagnosis of diseases associated with DNA transcription |
| 01/14/2009 | EP2014765A2 A novel species of acrocarpospora, a method of preparing iodinin, and the uses of iodinin |
| 01/14/2009 | EP2014677A1 A-33 related antigens and their pharmacological uses |
| 01/14/2009 | EP2014672A1 8-beta-substituted estratrienes as selectively active estrogens |
| 01/14/2009 | EP2014670A2 Production of Glucosinolates from Agricultural By-Products and Waste |
| 01/14/2009 | EP2014663A1 Thieno-pyrimidyl amines as modulators of EP2 receptors |
| 01/14/2009 | EP2014662A1 Indolyl alkyl thieno-pyrimidyl amines as modulators of EP2 receptors |